Published Date: 17 Mar 2023
The American College of Rheumatology (ACR) and the American College of Hip Surgery (AAHKS) have released new guidelines.
Read Full NewsSusan Corbridge, PhD, and Alanna Kavannagh, MSN, CCRN, discuss the role of advanced practice providers on the evolving pulmonary and critical care teams during CHEST 2025.
The phase 3 study aims to confirm findings from the HEALEY ALS platform trial in patients with early-stage rapidly progressive ALS, which suggested potential benefits of pridopidine across multiple domains.
Holzem spoke in this interview about several additional highlights from her session at SDPA Fall regarding red flags in dermatology and when to admit from the clinic.
Key Skin Cancer Terms Not Understood by Almost 1/3 of Patients Surveyed
1.
Enhanced CAR T cell therapy offers new strategy for lymphoma
2.
Prostate cancer, rectal exams, Casgevy approved for thalassemia, and two million cancer cases.
3.
Study reveals increase in late-stage breast cancer diagnoses in US
4.
Doctors say lung cancer is still the deadliest cancer, but hope is growing
5.
Scientists develop novel adjuvant delivery system to enhance cancer vaccine effectiveness
1.
Beyond the Standard: Personalized Cancer Vaccines and the Dawn of a New Era in Pediatric Oncology
2.
Understanding Macrocytosis: Causes, Symptoms, and Treatment Options
3.
Breaking Down the Benefits and Risks of Hematopoietic Stem Cell Transplantation
4.
ctDNA in Aggressive B-Cell Lymphoma: Redefining MRD and Prognostic Monitoring
5.
Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
3.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation